- 6.0CiteScore
- 25 daysTime to First Decision
Special Issues
Journal of Personalized Medicine publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Oxidative Stress and Antioxidant Therapy in Diseases
Deadline: 30 November 2026
New Updates and Challenges in Personalized Orthopaedics
Deadline: 30 November 2026
Molecular and Technological Horizons in Ophthalmology: Precision Medicine from Artificial Intelligence to Optogenetic Vision Restoration
Deadline: 30 November 2026
Advancing Personalized Medicine in Inflammatory Disorders of the Gut
Deadline: 30 November 2026
Application of Medical Informatics and Knowledge-Based Ecosystem Management in Disease Diagnosis
Deadline: 30 November 2026
Precision Medicine in Anesthesia and Pain
Deadline: 25 November 2026
New Perspectives on Personalized Treatment Strategies of Obstetrics and Gynecology Oncology
Deadline: 25 November 2026
Personalized Medicine in Neurosurgery: Novel Prospectives and Challenges
Deadline: 25 November 2026
Precision Medicine in Hematology–Oncology: Recent Progress and Challenges
Deadline: 25 November 2026
Personalized Medicine in ENT and AI
Deadline: 20 November 2026
Recent Research on Personalized Approaches to Clinical Therapeutics and Medication Safety
Deadline: 31 October 2026
Clinical Advances and Innovations in Reconstructive and Plastic Surgery
Deadline: 31 October 2026
of 56

